Glitazones and Endothelial Function (GATE)

This study has been terminated.

( Terminated at 50% enrollment due to recent concerns about rosiglitazone )

Study NCT00203632 Information provided by University of Calgary

First Received: September 13, 2005 Last Updated: October 30, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	October 2007
Estimated Primary Completion Date:	No date given